CAMBRIDGE, Mass., April 3 /PRNewswire/ -- Xanthus Pharmaceuticals, Inc., a privately-held oncology drug development company, today announced that Richard T. Dean, Ph.D., Chief Executive Officer of Xanthus, will present a corporate overview at the BIO 2006 Annual International Convention on Monday, April 10th at 3:30 pm at the McCormick Place Convention Center in Chicago, IL.
About Xanthus Pharmaceuticals, Inc.
Xanthus Pharmaceuticals, Inc. is developing a portfolio of novel, clinical-stage, small-molecule oncology candidates through a management team whose accomplished track record encompasses all aspects of drug development, from discovery through regulatory approval and commercialization. The Company is applying its expertise both to advance its current pipeline and expand it into indications of unmet medical need beyond oncology.
Xanthus is headquartered in Cambridge, Massachusetts with an additional facility in Montreal, Quebec. More information is available at http://www.xanthus.com.
Contacts:
Kari Watson, MacDougall Biomedical Communications, Inc. -- kwatson@macbiocom.com or (508) 647-0209
John A. McCarthy, Jr., Senior Vice President & CFO, Xanthus Pharmaceuticals, Inc. -- john.mccarthy@xanthus.com or (617) 225-0522, x 125
Xanthus Pharmaceuticals, Inc.
CONTACT: Kari Watson of MacDougall Biomedical Communications, Inc., forXanthus Pharmaceuticals, Inc., +1-508-647-0209, kwatson@macbiocom.com; orJohn A. McCarthy, Jr., Senior Vice President & CFO of XanthusPharmaceuticals, Inc., +1-617-225-0522, ext. 125, john.mccarthy@xanthus.com
Web site: http://www.xanthus.com/
